These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
220 related articles for article (PubMed ID: 8112341)
1. Site-specific mutagenesis of residues in the human C5a anaphylatoxin which are involved in possible interaction with the C5a receptor. Bubeck P; Grötzinger J; Winkler M; Köhl J; Wollmer A; Klos A; Bautsch W Eur J Biochem; 1994 Feb; 219(3):897-904. PubMed ID: 8112341 [TBL] [Abstract][Full Text] [Related]
2. A recombinant hybrid anaphylatoxin with dual C3a/C5a activity. Bautsch W; Kretzschmar T; Stühmer T; Kola A; Emde M; Köhl J; Klos A; Bitter-Suermann D Biochem J; 1992 Nov; 288 ( Pt 1)(Pt 1):261-6. PubMed ID: 1445269 [TBL] [Abstract][Full Text] [Related]
3. Site-specific mutations in the N-terminal region of human C5a that affect interactions of C5a with the neutrophil C5a receptor. Carney DF; Hugli TE Protein Sci; 1993 Sep; 2(9):1391-9. PubMed ID: 8401225 [TBL] [Abstract][Full Text] [Related]
4. Site-directed mutagenesis of conserved charged residues in the helical region of the human C5a receptor. Arg2O6 determines high-affinity binding sites of C5a receptor. Raffetseder U; Röper D; Mery L; Gietz C; Klos A; Grötzinger J; Wollmer A; Boulay F; Köhl J; Bautsch W Eur J Biochem; 1996 Jan; 235(1-2):82-90. PubMed ID: 8631370 [TBL] [Abstract][Full Text] [Related]
5. Mutation of glutamate 199 of the human C5a receptor defines a binding site for ligand distinct from the receptor N terminus. Monk PN; Barker MD; Partridge LJ; Pease JE J Biol Chem; 1995 Jul; 270(28):16625-9. PubMed ID: 7622471 [TBL] [Abstract][Full Text] [Related]
6. Residues 21-30 within the extracellular N-terminal region of the C5a receptor represent a binding domain for the C5a anaphylatoxin. Chen Z; Zhang X; Gonnella NC; Pellas TC; Boyar WC; Ni F J Biol Chem; 1998 Apr; 273(17):10411-9. PubMed ID: 9553099 [TBL] [Abstract][Full Text] [Related]
7. Mapping the ligand-binding site on the C5a receptor: arginine74 of C5a contacts aspartate282 of the C5a receptor. Cain SA; Coughlan T; Monk PN Biochemistry; 2001 Nov; 40(46):14047-52. PubMed ID: 11705397 [TBL] [Abstract][Full Text] [Related]
8. A selection system to study C5a-C5a-receptor interactions: phage display of a novel C5a anaphylatoxin, Fos-C5aAla27. Hennecke M; Kola A; Baensch M; Wrede A; Klos A; Bautsch W; Köhl J Gene; 1997 Jan; 184(2):263-72. PubMed ID: 9031638 [TBL] [Abstract][Full Text] [Related]
9. Identification of a receptor-binding region in the core segment of the human anaphylatoxin C5a. Vlattas I; Sytwu II; Dellureficio J; Stanton J; Braunwalder AF; Galakatos N; Kramer R; Seligmann B; Sills MA; Wasvary J J Med Chem; 1994 Aug; 37(17):2783-90. PubMed ID: 8064805 [TBL] [Abstract][Full Text] [Related]
10. Receptor activation by human C5a des Arg74 but not intact C5a is dependent on an interaction between Glu199 of the receptor and Lys68 of the ligand. Crass T; Bautsch W; Cain SA; Pease JE; Monk PN Biochemistry; 1999 Jul; 38(30):9712-7. PubMed ID: 10423250 [TBL] [Abstract][Full Text] [Related]
11. Functional expression of a human C5a receptor clone in Xenopus oocytes requires additional RNA. Kroll B; Emde M; Jeromin A; Penner L; Rechkemmer G; Kretzschmar T; Klos A; Köhl J; Bautsch W FEBS Lett; 1991 Oct; 291(2):208-10. PubMed ID: 1718782 [TBL] [Abstract][Full Text] [Related]
12. Stabilization of an isolated helical capping box in solution by hydrophobic interactions: evidence from the NMR study of bioactive peptides from the C-terminus of human C5a anaphylatoxin. Ni F; Carpenter KA; Ripoll DR; Sanderson SD; Hugli TE Biopolymers; 1996 Jan; 38(1):31-41. PubMed ID: 8679942 [TBL] [Abstract][Full Text] [Related]
13. Primary structure and functional characterization of rat C5a: an anaphylatoxin with unusually high potency. Cui L; Carney DF; Hugli TE Protein Sci; 1994 Aug; 3(8):1169-77. PubMed ID: 7987212 [TBL] [Abstract][Full Text] [Related]
14. Modulation of ligand selectivity by mutation of the first extracellular loop of the human C5a receptor. Cain SA; Woodruff TM; Taylor SM; Fairlie DP; Sanderson SD; Monk PN Biochem Pharmacol; 2001 Jun; 61(12):1571-9. PubMed ID: 11377387 [TBL] [Abstract][Full Text] [Related]
15. Analysis of the C5a anaphylatoxin core domain using a C5a phage library selected on differentiated U937 cells. Kola A; Baensch M; Bautsch W; Klos A; Köhl J Mol Immunol; 1999 Feb; 36(2):145-52. PubMed ID: 10378686 [TBL] [Abstract][Full Text] [Related]
16. Chimeric receptors of the human C3a receptor and C5a receptor (CD88). Crass T; Ames RS; Sarau HM; Tornetta MA; Foley JJ; Köhl J; Klos A; Bautsch W J Biol Chem; 1999 Mar; 274(13):8367-70. PubMed ID: 10085065 [TBL] [Abstract][Full Text] [Related]
17. The NH2-terminal region of C5aR but not that of FPR is critical for both protein transport and ligand binding. Mery L; Boulay F J Biol Chem; 1994 Feb; 269(5):3457-63. PubMed ID: 8106386 [TBL] [Abstract][Full Text] [Related]
18. Epitope mapping of a C5a neutralizing mAb using a combined approach of phage display, synthetic peptides and site-directed mutagenesis. Kola A; Baensch M; Bautsch W; Hennecke M; Klos A; Casaretto M; Köhl J Immunotechnology; 1996 Jun; 2(2):115-26. PubMed ID: 9373320 [TBL] [Abstract][Full Text] [Related]
19. A detailed analysis of the C5a anaphylatoxin effector domain: selection of C5a phage libraries on differentiated U937 cells. Hennecke M; Otto A; Baensch M; Kola A; Bautsch W; Klos A; Köhl J Eur J Biochem; 1998 Feb; 252(1):36-44. PubMed ID: 9523709 [TBL] [Abstract][Full Text] [Related]
20. Solution structure of a unique C5a semi-synthetic antagonist: implications in receptor binding. Zhang X; Boyar W; Galakatos N; Gonnella NC Protein Sci; 1997 Jan; 6(1):65-72. PubMed ID: 9007977 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]